Pearl Diagnostics, Inc. — Form D
Pearl Diagnostics, Inc. of BALTIMORE, MD, a company, filed a Form D exempt-offering notice with the SEC on 2026-04-21. The offering totals $11.2M, of which $11.2M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2026-04-21
- Form: D
- Accession: 0001922830-26-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $11.2M
- Amount sold: $11.2M
- Minimum investment: $57K
- Investors: 21
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-581278
Issuer
- Name: Pearl Diagnostics, Inc.
- CIK: 0001922830
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 1812 ASHLAND AVENUE SUITE G32, BALTIMORE, MD, 21205
- Phone: 410.614.0300
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| John Cammack | Related Person | Baltimore, MD |
| Eric Gornstein | Related Person | Baltimore, MD |
| Kieren Marr | Related Person | Baltimore, MD |
| Brad Spellberg | Related Person | Baltimore, MD |
| Kieren Marr | Director | Baltimore, MD |
| Kieren Marr | Executive Officer | Baltimore, MD |
| Brad Spellberg | Director | Baltimore, MD |
| John Cammack | Director | Baltimore, MD |
Other filings by this issuer (1)
More